Delivery Order SPE2DB20D3101-SPE2DB25FRMY4

Award Date 6/13/25
Potential Completion Date 6/16/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,197.62, is for the supply of CORLANOR 5 MG TABLET 60S, a pharmaceutical product. The award is not set aside and has an ultimate completion date of May 15, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $5,460.17 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of CORLANOR 5 MG TABLET 60S, a pharmaceutical product, with a period of performance through February 6, 2025. The contract is a firm-fixed-price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,099.69 firm fixed-price contract is for the delivery of CORLANOR 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 11, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CORLANOR 5 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $5,174.89. The contract is a firm fixed price, non-set-aside award, indicating open competition. The delivery order has an ultimate completion date of May 16, 2025. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,809.83, is for the supply of 4,568,108,411 units of the medication Corlanor 5 mg tablet. The contract has an ultimate completion date of May 2, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CORLANOR 5 MG TABLET 60S. The contract has a firm fixed price of $4,625.06 and a completion date of July 30, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, and the Department of Justice Federal Bureau of Investigation, valued up...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,001.74 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563817620 CORLANOR 5 MG TABLET 60S. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CORLANOR 5 MG TABLET 60S. The contract has a ceiling value of $2,114.52 and an ultimate completion date of August 7, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $3,854.49 firm fixed-price contract is for the supply of CORLANOR 7.5 MG TABLET 60S, a medication used to treat heart failure. The contract has an ultimate completion date of June 4, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award is a Delivery Order with a Firm Fixed Price of $1,162.14 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CORLANOR 5 MG TABLET 60S, a prescription medication, to the Defense Logistics Agency, a defense agency. The contract has an ultimate completion date of June 6, 2025 and was awarded on June 5, 2025. The contract is not a set-aside and was competitively awarded....
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRMY4
    Delivery Order

This is a $15,445.42 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of CORLANOR 5 MG TABLET 60S. The contract has an ultimate completion date of June 16, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order contract is part of the company's broader support for federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 9/14/25, 1:08 AM